Based on fundamentals, market trends, company events and news, and other factors, equity analysts assign price targets and recommendations to buy or sell a stock. The following graph shows how a survey of multiple analysts recommend …
UTHR commands market capitalization of $3.38 billion, and it reported its latest EPS at $5.63. Its stock grew more than 63.57 percent in the past 52 weeks. The stock is mildly volatile with its beta at 0.93.Register withStockCall and …
(AP) _ United Therapeutics Corp. (UTHR) on Wednesday reported fourth-quarter earnings of $110.3 million. The Silver Spring, Maryland-based company said it had net income of $2.43 per share. Earnings, adjusted for stock option …
From 2007 through 2012, Dr. Sullivan was the Chief Medical Officer of United Therapeutics Corporation (“United Therapeutics”; Nasdaq: UTHR). From 2006 to 2012, Dr. Sullivan also served as the Chief Medical Officer of Lung Rx, …
Assuming they didn’t get out of this mess whole already, wealthy Russians might want to take what’s left of their deposits after a potential 40% heist in Cyprus and invest it in their home country. That’s if today’s “call of the day” is on ...
NEW YORK (CNN/Money) - DuPont stock climbed sharply higher on Monday, ranking as the largest percentage gainer on the Dow. The largest U.S. chemical company said it could spin off its $6.5 billion textiles and interiors businesses as …
Description: United Therapeutics develops and makes medicines for cardiovascular conditions, cancer and infectious diseases. Developments: Executives at United Therapeutics are hoping this year will be as good as 2004. Last year the …
NEW YORK, NY / ACCESSWIRE / July 27, 2017 / Pomerantz LLP is investigating claims on behalf of investors of …
United Therapeutics Corporation is a biotechnology company. The Company is focused on the development and commercialization of products for the treatment of chronic and life-threatening conditions. The Company markets and …
Oct 25 (Reuters) - United Therapeutics Corp :United Therapeutics Corporation reports third quarter 2017 financial results.Q3 revenue $446 million versus I/B/E/S view $426.4 million.United Therapeutics Corp - qtrly ‍SHR $6.27 .United …